Delivery Order 75N94020D00016-75N94025F00002
Award Date
8/1/25
Potential Completion Date
11/30/28
Potential Value
$724K
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Oregon Health & Science University (OHSU). The contract is for the pharmacokinetic/pharmacodynamic evaluation of levonorgestrel butanoate for female contraception, with a ceiling value of $622,909.06 and a period of performance through July 14, 2026. The contract is a delivery order and is not set aside for any...
This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for the clinical evaluation of novel female contraception products. The contract has a period of performance from November 9, 2015 to November 8, 2018, with an ultimate completion date of September 30, 2022. The contract is a firm fixed price award with a ceiling value of $160,379.14. It does not have a set-aside...
The National Institute of Child Health and Human Development (NICHD) awarded a $444,793.00 cost-no-fee delivery order contract to Oregon Health & Science University (OHSU) to provide a central laboratory for pharmacokinetic and pharmacodynamic evaluation of levonorgestrel butanoate for female contraception. This contract is part of NICHD's Contraceptive Development Program and Contraceptive Clinical Trials Network. The contract has a period of performance through February 8, 2026 and does...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for the "Clinical Evaluation of Long-Acting Reversible Contraceptives (LARC)." The contract has a period of performance from September 25, 2015, to September 24, 2018, with an ultimate completion date of March 1, 2024, and a ceiling value of $682,341.24. The contract is a delivery order and is priced on a...
The federal contract award is to the Oregon Health & Science University (OHSU), a prominent research university and academic medical center, to conduct a randomized controlled clinical trial on a female contraceptive. The contract, valued at $619,729.00, was awarded by the U.S. government on April 1, 2004, with a completion date of September 30, 2007. The contract is a delivery order and is classified as cost no fee. OHSU is not a small business set-aside. The contract is part of OHSU's...
This federal contract award was made by the National Institute of Child Health and Human Development, a civilian agency, to Oregon Health & Science University (OHSU) for a Contraceptive Clinical Trial. The contract has a ceiling value of $653,663.79 and is a Delivery Order with a Cost No Fee pricing type. The contract does not have a set-aside designation. OHSU is a major research university and academic medical center that frequently receives federal funding through contracts and grants,...
This federal contract award, valued at $1,235,833.08, was issued by the National Institute of Child Health and Human Development (NICHD) to Oregon Health & Science University (OHSU) to conduct a multi-center, randomized study evaluating the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy, and safety of daily oral low dose ulipristal acetate. The contract is not set aside for any specific business type. OHSU has subcontracted portions of the work to the University of...
This is a federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU) for an open-label trial on the efficacy, cycle control, and safety of a contraceptive vaginal ring delivering a daily dose of Nestorone and ethinyl estradiol. The contract has a ceiling value of $1,406,546.35 and does not have a set-aside designation. OHSU is a prominent research university and academic medical center that...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Oregon Health & Science University (OHSU), a U.S. state government, educational institution, and state-controlled institution of higher learning. The $133,612.31 contract is for the provision of assistance in protocol review, protocol development, and activities associated with the past, present, and future of the Contraceptive Clinical Trials Network (CCTN)...
Oregon Health & Science University was awarded a delivery order against an indefinite-delivery/indefinite-quantity contract vehicle by the National Institutes of Health National Institute of Child Health and Human Development. The $446,266.45 contract calls for Oregon Health & Science University to serve as the central laboratory for a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, effects on the mechanisms of contraceptive efficacy and safety...